SYMLIN Side Effects

7021561-2 | Blood Glucose Increased, Cerebrovascular Accident, Confusional State, Dizziness, Glycosylated Haemoglobin Increased, Hypertension, Incorrect Dose Administered, Memory Impairment, Nausea
on Sep 13, 2010 Female patient from UNITED STATES , 85 years of age, weighting 230.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, cerebrovascular accident, confusional state, dizziness (What is dizziness?), glycosylated haemoglobin increased, hypertension, incorrect dose administered, memory impairment, nausea (What is nausea?). Symlin dosage: 60 Mcg;tid;sc, 30 Mcg;tid;sc, 15 Mcg;tid;sc, 60 Mcg;tid;sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

7014355-5 | Abscess Limb, Arthropod Bite, Blood Glucose Decreased, Pneumonia Aspiration, Pyrexia, Renal Failure, Swelling, Vomiting
Patient was taking Symlin (View Usage). Patient had the following side effects: abscess limb, arthropod bite, blood glucose decreased, pneumonia aspiration, pyrexia, renal failure, swelling, vomiting on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 194.0 lb, was diagnosed with type 1 diabetes mellitus and. Symlin dosage: 15 Mcg;bid;sc, 15 Mcg;bid;sc. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BESYLATE (CON.) (View Besylate (con.) Review and Besylate (con.) Label ), CRESTOR (CON.) (View Crestor (con.) Review and Crestor (con.) Label ), NITROGLYCERIN (CON.) (View Nitroglycerin (con.) Review and Nitroglycerin (con.) Label ), NOVOLOG (CON.) (View Novolog (con.) Review and Novolog (con.) Label ), METOPROLOL (CON.) (View Metoprolol (con.) Review and Metoprolol (con.) Label ), ISOSORBIDE MONONITRATE (CON.) (View Isosorbide Mononitrate (con.) Review and Isosorbide Mononitrate (con.) Label ). Patient was hospitalized.

7014353-1 | Blood Glucose Decreased, Confusional State, Fall, Gait Disturbance, Malaise, Weight Increased
Adverse event was reported on Sep 07, 2010 by a Female patient taking Symlin (View Usage) (Dosage: 150 Mcg; Tid; Sc, 30 Mcg; Tid; Sc) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 70 years of age, weighting 277.0 lb, After Symlin was administered, patient had the following side effects: blood glucose decreased, confusional state, fall (What is fall?), gait disturbance, malaise, weight increased. During the same period patient was treated with NOVOLIN R (CON.) (View Novolin R (con.) Review and Novolin R (con.) Label ), LANTUS (CON.) (View Lantus (con.) Review and Lantus (con.) Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6946551-7 | Back Pain, Blood Creatinine Increased, Blood Glucose Increased, Cardiac Failure, Cerebrovascular Accident, Dizziness, Fall, Kidney Infection, Nausea
on Aug 09, 2010 Female patient from UNITED STATES , 74 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), blood creatinine increased, blood glucose increased, cardiac failure, cerebrovascular accident, dizziness (What is dizziness?), fall (What is fall?), kidney infection, nausea (What is nausea?). Symlin dosage: Tid; Sc. During the same period patient was treated with APIDRA (View Apidra Review and Apidra Label ), COZAAR (View Cozaar Review and Cozaar Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), THYROID (View Thyroid Review and Thyroid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.


6864670-0 | Asthenia, Blood Glucose Decreased, Hyperhidrosis, Nausea, Prostate Cancer, Tremor
on Jul 06, 2010 Male patient from UNITED STATES , 63 years of age, weighting 200.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient had the following side effects: asthenia, blood glucose decreased, hyperhidrosis, nausea (What is nausea?), prostate cancer (What is prostate cancer?), tremor. Symlin dosage: 120 Mcg;bid;sc, 60 Mcg;tid;sc. During the same period patient was treated with NOVOLOG (Tid) (View Novolog Review and Novolog Label ), LEVEMIR (View Levemir Review and Levemir Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ). Patient was hospitalized.

6864669-4 | Arthralgia, Blood Glucose Increased, Cardiac Flutter, Nausea
Patient was taking Symlin (View Usage). After Symlin was administered, patient had the following side effects: arthralgia, blood glucose increased, cardiac flutter, nausea (What is nausea?) on Jul 06, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 166.0 lb, was diagnosed with type 2 diabetes mellitus and. Symlin dosage: 45 Mcg;tid;sc, 60 Mcg;tid, Sc, 15 Mcg; Sc. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), ZOCOR (View Zocor Review and Zocor Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), MOBIC (View Mobic Review and Mobic Label ). Patient was hospitalized.

6836560-0 | Blood Glucose Increased, Fungal Infection, Ovarian Cancer Recurrent, Platelet Count Decreased, Pneumonia, Respiratory Failure
Adverse event was reported on Jun 22, 2010 by a Female patient taking Symlin (View Usage) (Dosage: 120 Mcg;tid;sc) was diagnosed with type 2 diabetes mellitus and. Location: , 57 years of age, weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, fungal infection (What is fungal infection?), ovarian cancer recurrent, platelet count decreased, pneumonia (What is pneumonia?), respiratory failure. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), STOOL SOFTENER (View Stool Softener Review and Stool Softener Label ). Patient was hospitalized.

6814832-3 | Foot Operation, Surgery, Tremor
on Jun 11, 2010 Female patient from UNITED STATES , 70 years of age, was treated with Symlin (View Usage). Patient had the following side effects: foot operation, surgery (What is surgery?), tremor. Symlin dosage: ; Sc. Patient was hospitalized.

6798360-X | Asthenia, Blood Glucose Decreased, Hyperhidrosis, Nausea, Prostate Cancer, Tremor
on Jun 09, 2010 Male patient from UNITED STATES , 63 years of age, weighting 200.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). After Symlin was administered, patient had the following side effects: asthenia, blood glucose decreased, hyperhidrosis, nausea (What is nausea?), prostate cancer (What is prostate cancer?), tremor. Symlin dosage: 120 Mcg;bid;sc 60 Mcg;bid;sc. During the same period patient was treated with NOVOLOG (60 Units;bid) (View Novolog Review and Novolog Label ), LEVEMIR (View Levemir Review and Levemir Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ). Patient was hospitalized.

6798351-9 | Cardiac Failure Congestive, Renal Failure, Respiratory Failure, Thrombosis, Weight Decreased
Patient was taking Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, renal failure, respiratory failure, thrombosis, weight decreased on Jun 07, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 274.0 lb, was diagnosed with type 2 diabetes mellitus and. Symlin dosage: 30 Mcg;tid;sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), NOVOLOG (View Novolog Review and Novolog Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6781061-1 | Dyspnoea
Adverse event was reported on Jun 17, 2010 by a Male patient taking Symlin (View Usage) (Dosage: 30 Mcg Tid Sq) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 58 years of age, weighting 345.0 lb, Patient had the following side effects: dyspnoea.

6773438-5 | Fungal Infection, Platelet Count Decreased, Pneumonia, Respiratory Failure
on May 27, 2010 Female patient from UNITED STATES , 57 years of age, weighting 160.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). After Symlin was administered, patient had the following side effects: fungal infection (What is fungal infection?), platelet count decreased, pneumonia (What is pneumonia?), respiratory failure. Symlin dosage: 60 Mcg; Bid; Sc, 45 Mcg; Bid; Sc, 30 Mcg; Bid; Sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), STOOL SOFTENER (View Stool Softener Review and Stool Softener Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), POTASSIUM (View Potassium Review and Potassium Label ). Patient was hospitalized.

6765661-0 | Activated Partial Thromboplastin Time Prolonged, Diarrhoea, International Normalised Ratio Increased, Malaise, Nausea, Prothrombin Time Prolonged
on May 26, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, diarrhoea, international normalised ratio increased, malaise, nausea (What is nausea?), prothrombin time prolonged. Symlin dosage: 120 Mcg; Tid; Sc 60 Mcg; Tid; Sc. During the same period patient was treated with LEVEMIR (View Levemir Review and Levemir Label ), COUMADIN (View Coumadin Review and Coumadin Label ), AMARYL (View Amaryl Review and Amaryl Label ), BENICAR (View Benicar Review and Benicar Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), EFFEXOR (View Effexor Review and Effexor Label ), XANAX (View Xanax Review and Xanax Label ).

6765660-9 | Blood Glucose Increased, Cardiac Failure Congestive, Dizziness, Nausea, Overdose, Skin Ulcer
Patient was taking Symlin (View Usage). Patient had the following side effects: blood glucose increased, cardiac failure congestive, dizziness (What is dizziness?), nausea (What is nausea?), overdose, skin ulcer on May 26, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 386.0 lb, was diagnosed with type 2 diabetes mellitus and. Symlin dosage: 60 Mcg;bid;sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), METFORMIN (View Metformin Review and Metformin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), CELEBREX (View Celebrex Review and Celebrex Label ), LASIX (View Lasix Review and Lasix Label ), ACTOS (View Actos Review and Actos Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

6759445-7 | Diarrhoea, International Normalised Ratio Increased, Malaise, Nausea
Adverse event was reported on May 19, 2010 by a Female patient taking Symlin (View Usage) (Dosage: 120 Mcg; Tid; Sc, 60 Mcg; Tid; Sc) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 52 years of age, After Symlin was administered, patient had the following side effects: diarrhoea, international normalised ratio increased, malaise, nausea (What is nausea?). During the same period patient was treated with LEVEMIR (View Levemir Review and Levemir Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6734600-0 | Blood Glucose Increased, Treatment Noncompliance
on May 06, 2010 Female patient from UNITED STATES , 51 years of age, weighting 215.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, treatment noncompliance. Symlin dosage: 60 Mcg;tid;sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), HUMALOG R (View Humalog R Review and Humalog R Label ), ACTOS/METFORMIN (View Actos/metformin Review and Actos/metformin Label ), JANUVIA (View Januvia Review and Januvia Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6734599-7 | Blood Glucose Increased, Cardiac Flutter, Electrocardiogram Abnormal, Nausea
on May 04, 2010 Female patient from UNITED STATES , 77 years of age, weighting 166.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient had the following side effects: blood glucose increased, cardiac flutter, electrocardiogram abnormal, nausea (What is nausea?). Symlin dosage: 15 Mcg;sc ; 60 Mcg;tid;sc. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), ZOCOR (View Zocor Review and Zocor Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), MOBIC (View Mobic Review and Mobic Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6719270-X | Pancreaticoduodenectomy, Weight Decreased
Patient was taking Symlin (View Usage). After Symlin was administered, patient had the following side effects: pancreaticoduodenectomy, weight decreased on Apr 23, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 159.0 lb, was diagnosed with type 2 diabetes mellitus and. Symlin dosage: 120 Mcg;bid;sc, 60 Mcg;bid;sc. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), FLOMAX (View Flomax Review and Flomax Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

6711213-8 | Blood Glucose Decreased, Blood Glucose Increased, Dizziness, Feeling Abnormal, Somnolence
Adverse event was reported on Aug 27, 2009 by a Male patient taking Symlin (View Usage) (Dosage: 120 Mcg;tid;sc) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 69 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose increased, dizziness (What is dizziness?), feeling abnormal, somnolence. During the same period patient was treated with LANTUS (CON.) (View Lantus (con.) Review and Lantus (con.) Label ), NOVOLOG (CON.) (View Novolog (con.) Review and Novolog (con.) Label ).

6711212-6 | Hypoglycaemic Unconsciousness
on Sep 23, 2009 Female patient from UNITED STATES , 35 years of age, weighting 100.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). Patient had the following side effects: hypoglycaemic unconsciousness. Symlin dosage: 60 Mcg;tid;sc; 15 Mcg;tid; Sc. During the same period patient was treated with LANTUS (CON.) (View Lantus (con.) Review and Lantus (con.) Label ), HUMALOG (View Humalog Review and Humalog Label ).

6711208-4 | Blood Glucose Decreased, Blood Glucose Fluctuation, Fall
on Sep 28, 2009 Female patient from UNITED STATES , 50 years of age, weighting 200.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). After Symlin was administered, patient had the following side effects: blood glucose decreased, blood glucose fluctuation, fall (What is fall?). Symlin dosage: 60 Mcg;tid;sc. During the same period patient was treated with HUMALOG (Pump) (View Humalog Review and Humalog Label ).

6711207-2 | Blood Glucose Decreased
Patient was taking Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased on Jun 11, 2009 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with type 1 diabetes mellitus and. Symlin dosage: 60 Mcg;bid;sc; 15 Mcg;bid;sc;sc.

6711204-7 | Hypoglycaemia, Hypoglycaemia Unawareness, Nausea
Adverse event was reported on Jun 29, 2009 by a Female patient taking Symlin (View Usage) (Dosage: 60 Mcg;itd;sc; 45 Mcg;tid;sc; 30 Mcg;tid; Sc; 15 Mcg;tid; Sc) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , 48 years of age, weighting 183.0 lb, Patient had the following side effects: hypoglycaemia, hypoglycaemia unawareness, nausea (What is nausea?). During the same period patient was treated with HUMALOG (CON.) (View Humalog (con.) Review and Humalog (con.) Label ), INSULIN (CON.) (View Insulin (con.) Review and Insulin (con.) Label ).

6711194-7 | Blood Glucose Decreased, Dizziness, Feeling Abnormal, Hypoglycaemic Unconsciousness, Nausea
on Jul 21, 2009 Female patient from UNITED STATES , 61 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). After Symlin was administered, patient had the following side effects: blood glucose decreased, dizziness (What is dizziness?), feeling abnormal, hypoglycaemic unconsciousness, nausea (What is nausea?). Symlin dosage: 60 Mcg;tid;sc; 45 Mcg;tid;sc; 30 Mcg;tid; Sc; 15 Mcg;tid;sc. During the same period patient was treated with HUMALOG (CON.) (View Humalog (con.) Review and Humalog (con.) Label ), LANTUS (CON.) (View Lantus (con.) Review and Lantus (con.) Label ).

6711193-5 | Hypoglycaemia
on Jun 09, 2009 Female patient from UNITED STATES , 19 years of age, weighting 151.9 lb, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Symlin dosage: 5 Mcg;qh;pump. During the same period patient was treated with HUMALOG (CON.) (View Humalog (con.) Review and Humalog (con.) Label ), ZOCOR (CON.) (View Zocor (con.) Review and Zocor (con.) Label ), ALLEGRA (CON.) (View Allegra (con.) Review and Allegra (con.) Label ), SINGULAIR (CON.) (View Singulair (con.) Review and Singulair (con.) Label ).

6711192-3 | Hypoglycaemia
Patient was taking Symlin (View Usage). Patient had the following side effects: hypoglycaemia on Jun 09, 2009 from UNITED STATES Additional patient health information: Male patient , 21 years of age, weighting 57.76 lb, was diagnosed with type 1 diabetes mellitus and. Symlin dosage: 3 Mcg;qh;pump. During the same period patient was treated with HUMALOG (CON.) (View Humalog (con.) Review and Humalog (con.) Label ).

6711191-1 | Hypoglycaemia
Adverse event was reported on Jun 09, 2009 by a Male patient taking Symlin (View Usage) (Dosage: 3 Mcg;qh;pump) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , 16 years of age, weighting 156.3 lb, After Symlin was administered, patient had the following side effects: hypoglycaemia. During the same period patient was treated with HUMALOG(CON.) (View Humalog(con.) Review and Humalog(con.) Label ).

6686725-6 | Blood Glucose Increased, Dizziness, Fall, Head Injury, Insomnia, Memory Impairment, Pain, Somnolence
on Apr 06, 2010 Male patient from UNITED STATES , 57 years of age, weighting 275.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, dizziness (What is dizziness?), fall (What is fall?), head injury, insomnia, memory impairment, pain (What is pain?), somnolence. Symlin dosage: 60 Mcg;tid;sc. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), BUSPIRONE HCL (View Buspirone Hcl Review and Buspirone Hcl Label ), DIOVAN (View Diovan Review and Diovan Label ), PENTAZOCINE (View Pentazocine Review and Pentazocine Label ), NALOXONE (View Naloxone Review and Naloxone Label ), CARISOPRODOL/ASA (View Carisoprodol/asa Review and Carisoprodol/asa Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ). Patient was hospitalized.

6686720-7 | Cardiac Failure Congestive, Decreased Appetite, Dehydration, Depressed Level Of Consciousness, Fluid Overload, Headache, Mental Status Changes, Rash
on Apr 01, 2010 Female patient from UNITED STATES , 51 years of age, weighting 382.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient had the following side effects: cardiac failure congestive, decreased appetite, dehydration, depressed level of consciousness, fluid overload, headache (What is headache?), mental status changes, rash (What is rash?). Symlin dosage: 45 Mcg Tid;sc, 15 Mcg, Tid, Sc, 15 Mcg, Tid, Sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), NOVOLOG (View Novolog Review and Novolog Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), KEPPRA (View Keppra Review and Keppra Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ). Patient was hospitalized.

6686718-9 | Breast Cancer, Breast Cancer Metastatic, Cardiac Failure Congestive, Carotid Artery Dissection, Cerebrovascular Accident, Metastases To Central Nervous System, Metastases To Lung
Patient was taking Symlin (View Usage). After Symlin was administered, patient had the following side effects: breast cancer (What is breast cancer?), breast cancer metastatic, cardiac failure congestive, carotid artery dissection, cerebrovascular accident, metastases to central nervous system, metastases to lung on Mar 31, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, was diagnosed with type 2 diabetes mellitus and. Symlin dosage: 60 Mcg;tid;sc. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), LANTUS (View Lantus Review and Lantus Label ), COREG (View Coreg Review and Coreg Label ), ZOCOR (View Zocor Review and Zocor Label ), NEXIUM (View Nexium Review and Nexium Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6672737-5 | Decreased Appetite, Dehydration, Headache, Nausea, Renal Failure Acute, Weight Decreased
Adverse event was reported on Mar 22, 2010 by a Female patient taking Symlin (View Usage) (Dosage: 60 Mcg;tid;sc, 15 Mcg;tid;sc, 15 Mcg;tid;sc) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 51 years of age, weighting 360.0 lb, Patient experienced the following unwanted or unexpected effects: decreased appetite, dehydration, headache (What is headache?), nausea (What is nausea?), renal failure acute, weight decreased. During the same period patient was treated with NOVOLOG (View Novolog Review and Novolog Label ). Patient was hospitalized.

6666390-4 | Breast Cancer Metastatic, Cardiac Failure Congestive, Carotid Artery Dissection, Cerebrovascular Accident, Metastases To Central Nervous System, Metastases To Lung
on Mar 16, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient had the following side effects: breast cancer metastatic, cardiac failure congestive, carotid artery dissection, cerebrovascular accident, metastases to central nervous system, metastases to lung. Symlin dosage: ;sc. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), LANTUS (View Lantus Review and Lantus Label ), COREG (View Coreg Review and Coreg Label ), ZOCOR (View Zocor Review and Zocor Label ), NEXIUM (View Nexium Review and Nexium Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6619904-4 | Abdominal Distension, Abdominal Pain Upper, Blood Glucose Decreased, Blood Glucose Increased, Decreased Appetite, Diabetes Mellitus Inadequate Control, Dialysis, Hypophagia
on Feb 23, 2010 Female patient from UNITED STATES , 54 years of age, weighting 125.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). After Symlin was administered, patient had the following side effects: abdominal distension, abdominal pain upper, blood glucose decreased, blood glucose increased, decreased appetite, diabetes mellitus inadequate control, dialysis (What is dialysis?), hypophagia. Symlin dosage: 120 Mcg; Tid; Sc. During the same period patient was treated with SYMLINPEN (PRAMLINTIDE ACETATE) PEN INJECTOR (0.6 MG/ML) (; Sc) (View Symlinpen (pramlintide Acetate) Pen-injector (0.6 Mg/ml) Review and Symlinpen (pramlintide Acetate) Pen-injector (0.6 Mg/ml) Label ), HUMALOG (View Humalog Review and Humalog Label ), PLAVIX (View Plavix Review and Plavix Label ), NEURONTIN (View Neurontin Review and Neurontin Label ).

6619901-9 | Spinal Fracture, Weight Increased
Patient was taking Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: spinal fracture, weight increased on Feb 22, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with weight control (What is weight control?) and. Symlin dosage: 120 Mcg; Tid; Sc. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CALCIUM (View Calcium Review and Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GARLIC (View Garlic Review and Garlic Label ). Patient was hospitalized.

6609252-0 | Blood Glucose Increased, Fatigue, Glycosylated Haemoglobin, Malaise, Myalgia
Adverse event was reported on Feb 09, 2010 by a Female patient taking Symlin (View Usage) (Dosage: 60 Mcg; Tid; Sc) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 54 years of age, Patient had the following side effects: blood glucose increased, fatigue, glycosylated haemoglobin, malaise, myalgia. During the same period patient was treated with NOVOLOG (View Novolog Review and Novolog Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6602635-4 | Blood Glucose Increased, Blood Pressure Increased, Feeling Abnormal, Loss Of Consciousness, Nausea
on Feb 03, 2010 Female patient from UNITED STATES , 54 years of age, weighting 191.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). After Symlin was administered, patient had the following side effects: blood glucose increased, blood pressure increased, feeling abnormal, loss of consciousness, nausea (What is nausea?). Symlin dosage: 60 Mcg;tid;sc. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), NOVOLOG (View Novolog Review and Novolog Label ), DIOVAN (View Diovan Review and Diovan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6602261-7 | Abdominal Distension, Clostridial Infection, Decreased Appetite, Idiopathic Thrombocytopenic Purpura, Increased Appetite, Pancreas Transplant, Renal Transplant, Therapeutic Response Unexpected, Weight Increased
on Feb 03, 2010 Female patient from UNITED STATES , 32 years of age, weighting 199.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, clostridial infection, decreased appetite, idiopathic thrombocytopenic purpura, increased appetite, pancreas transplant (What is pancreas transplant?), renal transplant, therapeutic response unexpected, weight increased. Symlin dosage: 60 Mcg;qd;sc ; 120 Mcg;tid;sc ; 60 Mcg;tid;sc. During the same period patient was treated with NOVOLOG (View Novolog Review and Novolog Label ), LANTUS (View Lantus Review and Lantus Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6580644-1 | Dizziness, Fall, Loss Of Consciousness, Nausea
Patient was taking Symlin (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), loss of consciousness, nausea (What is nausea?) on Jan 25, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, was diagnosed with type 2 diabetes mellitus, diabetic neuropathy and. Symlin dosage: 60 Mcg; Tid; Sc. During the same period patient was treated with NEURONTIN (300 Mg; Tid; Po) (View Neurontin Review and Neurontin Label ), HUMALOG (View Humalog Review and Humalog Label ).

6580637-4 | Blood Cholesterol Increased, Blood Magnesium Decreased, Chest Pain, Nephropathy, Pancreatitis Acute, Renal Failure Acute, Troponin Increased
Adverse event was reported on Jan 19, 2010 by a Male patient taking Symlin (View Usage) (Dosage: 60 Mcg; Sc) was diagnosed with type 2 diabetes mellitus, imaging procedure and. Location: UNITED STATES , 56 years of age, weighting 330.0 lb, After Symlin was administered, patient had the following side effects: blood cholesterol increased, blood magnesium decreased, chest pain (What is chest pain?), nephropathy, pancreatitis acute, renal failure acute, troponin increased. During the same period patient was treated with JANUMET (; Bid;) (View Janumet Review and Janumet Label ), BENAZEPRIL HYDROCHLORIDE (40 Mg; Qd;) (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), TEKTURNA (300 Mg; Qd;) (View Tekturna Review and Tekturna Label ), CONTRAST MEDIA (; X1;) (View Contrast Media Review and Contrast Media Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), SIMAVASTATIN (View Simavastatin Review and Simavastatin Label ), COENZYME K (View Coenzyme-k Review and Coenzyme-k Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

6568412-8 | Back Pain, Fracture
on Jan 13, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), fracture (What is fracture?). Symlin dosage: 120 Mcg; Tid; Sc. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CALCIUM (View Calcium Review and Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GARLIC (View Garlic Review and Garlic Label ). Patient was hospitalized.

6531670-X | Pancreatitis
on Jan 07, 2010 Male patient from UNITED STATES , 58 years of age, was treated with Symlin (View Usage). Patient had the following side effects: pancreatitis. Symlin dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), GLARGINE INSULIN (View Glargine Insulin Review and Glargine Insulin Label ), ASPART INSULIN (View Aspart Insulin Review and Aspart Insulin Label ), ACTOS (View Actos Review and Actos Label ), NIACIN (View Niacin Review and Niacin Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METFORMIN (View Metformin Review and Metformin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6526224-5 | Blood Glucose Increased, Blood Pressure Increased, Feeling Abnormal, Loss Of Consciousness, Nausea
Patient was taking Symlin (View Usage). After Symlin was administered, patient had the following side effects: blood glucose increased, blood pressure increased, feeling abnormal, loss of consciousness, nausea (What is nausea?) on Dec 15, 2009 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 191.0 lb, was diagnosed with type 2 diabetes mellitus and. Symlin dosage: 60 Mcg;tid;sc. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), NOVOLOG (Pump) (View Novolog Review and Novolog Label ), DIOVAN (View Diovan Review and Diovan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6521958-0 | Orthopedic Procedure
Adverse event was reported on Dec 18, 2009 by a Female patient taking Symlin (View Usage) (Dosage: Sc) . Location: UNITED STATES , 87 years of age, Patient experienced the following unwanted or unexpected effects: orthopedic procedure. During the same period patient was treated with CON MEDS (View Con Meds Review and Con Meds Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6468223-8 | Blood Glucose Increased, Decreased Appetite, Fall, Gastroenteritis Viral, Heart Rate Decreased, Hyperhidrosis, Hypoglycaemia, Injury Associated With Device, Loss Of Consciousness
on Nov 17, 2009 Female patient from UNITED STATES , 62 years of age, was diagnosed with diabetes mellitus and was treated with Symlin (View Usage). Patient had the following side effects: blood glucose increased, decreased appetite, fall (What is fall?), gastroenteritis viral, heart rate decreased, hyperhidrosis, hypoglycaemia, injury associated with device, loss of consciousness. Symlin dosage: 120 Mcg; Tid; Sc; 60 Mcg,tid: Sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), ANTIDEPRESSANTS (View Antidepressants Review and Antidepressants Label ). Patient was hospitalized.

6468222-6 | Back Pain, Bowel Movement Irregularity, Hypophagia
on Nov 10, 2009 Female patient from UNITED STATES , 56 years of age, weighting 165.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Symlin (View Usage). After Symlin was administered, patient had the following side effects: back pain (What is back pain?), bowel movement irregularity, hypophagia. Symlin dosage: 60 Mcg;tid; Sc 15 Mcg; Tid;sc. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CLINORIL (View Clinoril Review and Clinoril Label ), ANTIGLAUCOMA (View Antiglaucoma Review and Antiglaucoma Label ), PREPARATIONS (View Preparations Review and Preparations Label ), MIOTICS (View Miotics Review and Miotics Label ). Patient was hospitalized.

6468207-X | Blood Glucose Increased, Decreased Appetite, Fall, Gastroenteritis Viral, Heart Rate Decreased, Hyperhidrosis, Hypoglycaemia, Injury Associated With Device, Loss Of Consciousness
Patient was taking Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, decreased appetite, fall (What is fall?), gastroenteritis viral, heart rate decreased, hyperhidrosis, hypoglycaemia, injury associated with device, loss of consciousness on Nov 17, 2009 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with diabetes mellitus and. Symlin dosage: 120 Mcg; Tid; Sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), ANTIDEPRESSANTS (View Antidepressants Review and Antidepressants Label ). Patient was hospitalized.

6468206-8 | Back Pain, Bowel Movement Irregularity
Adverse event was reported on Nov 10, 2009 by a Female patient taking Symlin (View Usage) (Dosage: 60 Mcg; Tid; Sc) . Location: UNITED STATES , 56 years of age, weighting 165.0 lb, Patient had the following side effects: back pain (What is back pain?), bowel movement irregularity. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CLINORIL (View Clinoril Review and Clinoril Label ), ANTIGLAUCOMA PREPARATIONS AND MIOTICS (View Antiglaucoma Preparations And Miotics Review and Antiglaucoma Preparations And Miotics Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6443383-3 | Blood Glucose Increased, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Hypoglycaemic Unconsciousness, International Normalised Ratio Abnormal
on Oct 28, 2009 Female patient from UNITED STATES , 77 years of age, weighting 154.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Symlin (View Usage). After Symlin was administered, patient had the following side effects: blood glucose increased, chronic obstructive pulmonary disease, condition aggravated, hypoglycaemic unconsciousness, international normalised ratio abnormal. Symlin dosage: 105 Mcg; Qd; Sc. During the same period patient was treated with NOVOLOG (View Novolog Review and Novolog Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DUONEB (View Duoneb Review and Duoneb Label ), COUMADIN (View Coumadin Review and Coumadin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), NEXIUM (View Nexium Review and Nexium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KLOR CON (View Klor-con Review and Klor-con Label ). Patient was hospitalized.

6428634-3 | Blood Glucose Decreased, Blood Glucose Increased, Decreased Appetite, Fall, Gastroenteritis Viral, Heart Rate Decreased, Hyperhidrosis, Hypoglycaemia, Injury Associated With Device
on Oct 19, 2009 Female patient from UNITED STATES , 62 years of age, was diagnosed with diabetes mellitus and was treated with Symlin (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose increased, decreased appetite, fall (What is fall?), gastroenteritis viral, heart rate decreased, hyperhidrosis, hypoglycaemia, injury associated with device. Symlin dosage: 60 Mcg; Tid; Sc, 120 Mcg; Tid; Sc. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), ANTIDEPRESSANTS (View Antidepressants Review and Antidepressants Label ). Patient was hospitalized.

6411818-8 | Blood Glucose Increased, Weight Decreased
Patient was taking Symlin (View Usage). Patient had the following side effects: blood glucose increased, weight decreased on Oct 05, 2009 from UNITED STATES Additional patient health information: Female patient , 82 years of age, weighting 130.0 lb, was diagnosed with type 2 diabetes mellitus and. Symlin dosage: 30 Mcg; Tid; Sc. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), HUMALOG (View Humalog Review and Humalog Label ), LANTUS (View Lantus Review and Lantus Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.